The lymph node in HIV pathogenesis

Seminars in Immunology

Volumn 20, Issue 3, 2008, Pages 187-195

  Lederman, Michael M ^a   Margolis, Leonid ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

CD38; Cell cycle; HIV; Immune activation; Lymph Node; Microbial Translocation; Toll like receptors

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; B LYMPHOCYTE; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFLAMMATION; LYMPH NODE; LYMPHOCYTOPENIA; MEMORY T LYMPHOCYTE; NONHUMAN; PATHOGENESIS; PRIMATE; REVIEW; RHESUS MONKEY; SIMIAN VIRUS; T LYMPHOCYTE; UNITED STATES; VIRUS REPLICATION;

ANIMALS; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; LYMPH NODES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 50649120601     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2008.06.001     Document Type: Review

References (124)

1. Lane H.C., Volkman D.J., Whalen G., and Fauci A.S. In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements. J Exp Med 154 (1981) 1043-1057
2. Glushakova S., Grivel J.C., Fitzgerald W., Sylwester A., Zimmerberg J., and Margolis L.B. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat Med 4 (1998) 346-349
3. Bajenoff M., Egen J.G., Qi H., Huang A.Y., Castellino F., and Germain R.N. Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol 28 (2007) 346-352
4. Weaver C.T., Hatton R.D., Mangan P.R., and Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25 (2007) 821-852
5. Collier A.C., Corey L., Murphy V.L., and Handsfield H.H. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 109 (1988) 101-105
6. Kroon F.P., van Dissel J.T., de Jong J.C., and van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. Aids 8 (1994) 469-476
7. Valdez H., Smith K.Y., Landay A., et al., ACTG 375 Team. AIDS Clinical Trials Group. Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. Aids 14 (2000) 11-21
8. Luciano A.A., Lederman M.M., Valentin-Torres A., Bazdar D.A., and Sieg S.F. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease. J Immunol 179 (2007) 3543-3549
9. Sieg S.F., Bazdar D.A., and Lederman M.M. Impaired TCR-mediated induction of Ki67 by naive CD4+ T cells is only occasionally corrected by exogenous IL-2 in HIV-1 infection. J Immunol 171 (2003) 5208-5214
10. Sieg S.F., Harding C.V., and Lederman M.M. HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses. J Clin Invest 108 (2001) 757-764
11. Gruters R.A., Terpstra F.G., De Jong R., Van Noesel C.J., Van Lier R.A., and Miedema F. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur J Immunol 20 (1990) 1039-1044
12. Lane H.C., Depper J.M., Greene W.C., Whalen G., Waldmann T.A., and Fauci A.S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 313 (1985) 79-84
13. Miedema F., Petit A.J., Terpstra F.G., et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 82 (1988) 1908-1914
14. Migueles S.A., Laborico A.C., Shupert W.L., et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3 (2002) 1061-1068
15. Betts M.R., Nason M.C., West S.M., et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107 (2006) 4781-4789
16. Sieg S.F., Bazdar D.A., Harding C.V., and Lederman M.M. Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease. J Virol 75 (2001) 9983-9985
17. Abrams D.I., Lewis B.J., and Volberding P.A. Lymphadenopathy: endpoint or prodrome? Update of a 24-month prospective study. Ann N Y Acad Sci 437 (1984) 207-215
18. Metroka C.E., Cunningham-Rundles S., Pollack M.S., et al. Generalized lymphadenopathy in homosexual men. Ann Intern Med 99 (1983) 585-591
19. Schacker T., Collier A.C., Hughes J., Shea T., and Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125 (1996) 257-264
20. Tindall B., Barker S., Donovan B., et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 148 (1988) 945-949
21. Bucy R.P., Hockett R.D., Derdeyn C.A., et al. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 103 (1999) 1391-1398
22. Andersson J., Fehniger T.E., Patterson B.K., et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. Aids 12 (1998) F123-F129
23. Biancotto A., Grivel J.C., Iglehart S.J., et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109 (2007) 4272-4279
24. Schacker T.W., Nguyen P.L., Beilman G.J., et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 110 (2002) 1133-1139
25. Schacker T.W., Reilly C., Beilman G.J., et al. Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count. Aids 19 (2005) 2169-2171
26. Biberfeld P., Ost A., Porwit A., et al. Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand [A] 95 (1987) 47-65
27. Heath S.L., Tew J.G., Tew J.G., Szakal A.K., and Burton G.F. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377 (1995) 740-744
28. Dienstag D.L. Chronic viral hepatitis. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Priniciples and practice of infectious diseases (2005), Elsevier, Philadelphia, PA
29. Altfeld M., van Lunzen J., Frahm N., et al. Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest 109 (2002) 837-843
30. Brenchley J.M., Schacker T.W., Ruff L.E., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 (2004) 749-759
31. Cheynier R., Henrichwark S., Hadida F., et al. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78 (1994) 373-387
32. Connick E., Mattila T., Folkvord J.M., et al. CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J Immunol 178 (2007) 6975-6983
33. Knuchel M.C., Speck R.F., Schlaepfer E., et al. Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients. Aids 14 (2000) 2661-2669
34. Nilsson J., Kinloch-de-Loes S., Granath A., Sonnerborg A., Goh L.E., and Andersson J. Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection. Aids 21 (2007) 565-574
35. Morrow R., Fanta J., and Kerlen S. Tuberculosis screening and anergy in a homeless population. J Am Board Fam Pract 10 (1997) 1-5
36. Akramuzzaman S.M., Cutts F.T., Wheeler J.G., and Hossain M.J. Increased childhood morbidity after measles is short-term in urban Bangladesh. Am J Epidemiol 151 (2000) 723-735
37. Shaheen S.O., Aaby P., Hall A.J., et al. Cell mediated immunity after measles in Guinea-Bissau: historical cohort study. Bmj 313 (1996) 969-974
38. Perez-Blas M., Regueiro J.R., Ruiz-Contreras J.R., and Arnaiz-Villena A. T lymphocyte anergy during acute infectious mononucleosis is restricted to the clonotypic receptor activation pathway. Clin Exp Immunol 89 (1992) 83-88
39. Russell A.S., Percy J.S., and Grace M. The relationship of autoantibodies to depression of cell-mediated immunity in infectious mononucleosis. Clin Exp Immunol 20 (1975) 65-71
40. Rickinson A.B., and Moss D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15 (1997) 405-431
41. Hellerstein M.K., and McCune J.M. T cell turnover in HIV-1 disease. Immunity 7 (1997) 583-589
42. Kovacs J.A., Lempicki R.A., Sidorov I.A., et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 194 (2001) 1731-1741
43. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., and Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309 (1983) 453-458
44. Lederman M.M., Carey J.T., Schacter B., Aucott J., and Ellner J.J. Lymphocytes of persons with the acquired immunodeficiency syndrome and related conditions express reactivity with the monoclonal antibody 4D12 reflective of in vivo lymphocyte activation. Hum Immunol 20 (1987) 279-291
45. Sieg S.F., Rodriguez B., Asaad R., Jiang W., Bazdar D.A., and Lederman M.M. Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement. J Infect Dis 192 (2005) 62-70
46. Aukrust P., Liabakk N.B., Muller F., Espevik T., and Froland S.S. Activation of tumor necrosis factor-alpha system in HIV-1 infection: association with markers of immune activation. Infection 23 (1995) 9-15
47. Aziz N., Nishanian P., Taylor J.M., et al. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. J Infect Dis 179 (1999) 843-848
48. Breen E.C., Rezai A.R., Nakajima K., et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 144 (1990) 480-484
49. Giorgi J.V., Liu Z., Hultin L.E., Cumberland W.G., Hennessey K., and Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acq Immune Def Synd 6 (1993) 904-912
50. Gottlieb M.S., Schroff R., Schanker H.M., et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305 (1981) 1425-1431
51. Birdsall H.H., Trial J., Hallum J.A., et al. Phenotypic and functional activation of monocytes in HIV-1 infection: interactions with neural cells. J Leukoc Biol 56 (1994) 310-317
52. Braun D.P., Kessler H., Falk L., et al. Monocyte functional studies in asymptomatic, human immunodeficiency disease virus (HIV)-infected individuals. J Clin Immunol 8 (1988) 486-494
53. Gascon R.L., Narvaez A.B., Zhang R., et al. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. J Acq Immune Def Synd 30 (2002) 146-153
54. Jiang W., Lederman M.M., Salkowitz J.R., Rodriguez B., Harding C.V., and Sieg S.F. Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production. J Virol 79 (2005) 4109-4119
55. Moir S., Malaspina A., Pickeral O.K., et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med 200 (2004) 587-599
56. Deeks S.G., Kitchen C.M., Liu L., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104 (2004) 942-947
57. Giorgi J.V., Hultin L.E., McKeating J.A., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179 (1999) 859-870
58. Gardner M.B. SIV infected rhesus macaques: an AIDS model for immunoprevention and immunotherapy. Adv Exp Med Biol 251 (1989) 279-293
59. Kornfeld C., Ploquin M.J., Pandrea I., et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115 (2005) 1082-1091
60. Silvestri G., Sodora D.L., Koup R.A., et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18 (2003) 441-452
61. Silvestri G., Paiardini M., Pandrea I., Lederman M.M., and Sodora D.L. Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 117 (2007) 3148-3154
62. Sachsenberg N., Perelson A.S., Yerly S., et al. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med 187 (1998) 1295-1303
63. Lempicki R.A., Kovacs J.A., Baseler M.W., et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 97 (2000) 13778-13783
64. Hellerstein M., Hanley M.B., Cesar D., et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5 (1999) 83-89
65. Sieg SF, Bazdar D, Lederman MM. S phase entry leads to cell death in circulating T cells from HIV-infected persons. J Leukoc Biol 2008 Jun;83(6):1382-7. Epub 2008 Mar 27.
66. Masur H., Michelis M.A., Greene J.B., et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 305 (1981) 1431-1438
67. Fry T.J., Connick E., Falloon J., et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 97 (2001) 2983-2990
68. Napolitano L.A., Grant R.M., Deeks S.G., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7 (2001) 73-79
69. Autran B., Carcelain G., Li T.S., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease [see comments]. Science 277 (1997) 112-116
70. Lederman M.M., Connick E., Landay A., et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis 178 (1998) 70-79
71. Kovacs J.A., Vogel S., Metcalf J.A., et al. Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. Eur J Immunol 31 (2001) 1351-1360
72. Betts M.R., Ambrozak D.R., Douek D.C., et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75 (2001) 11983-11991
73. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
74. Macallan D.C., Wallace D., Zhang Y., et al. Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J Exp Med 200 (2004) 255-260
75. Wu C.Y., Kirman J.R., Rotte M.J., et al. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 3 (2002) 852-858
76. Zaph C., Uzonna J., Beverley S.M., and Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 10 (2004) 1104-1110
77. Riou C., Yassine-Diab B., Van grevenynghe J., et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med 204 (2007) 79-91
78. Badley A.D., Dockrell D.H., Algeciras A., et al. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 102 (1998) 79-87
79. Finkel T.H., Tudor-Williams G., Banda N.K., et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1 (1995) 129-134
80. Muro-Cacho C.A., Pantaleo G., and Fauci A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 154 (1995) 5555-5566
81. Riou C., Yassine-Diab B., Van Grevenynghe J., et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of central memory CD4+ T cells. J Exp Med 204 1 (2007 Jan 22) 79-91
82. van Grevenynghe J., Procopio F.A., He Z., et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat Med 14 (2008) 266-274
83. Lederman M.M., Ratnoff O.D., Scillian J.J., Jones P.K., and Schacter B. Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med 308 (1983) 79-83
84. Menitove J.E., Aster R.H., Casper J.T., et al. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med 308 (1983) 83-86
85. Mackall C.L., Fleisher T.A., Brown M.R., et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89 (1997) 3700-3707
86. Herbeuval J.P., Hardy A.W., Boasso A., et al. Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 102 (2005) 13974-13979
87. Wolthers K.C., Bea G., Wisman A., et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 274 (1996) 1543-1547
88. Picker L.J., Hagen S.I., Lum R., et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J Exp Med 200 (2004) 1299-1314
89. Okoye A., Meier-Schellersheim M., Brenchley J.M., et al. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204 (2007) 2171-2185
90. Schacker T.W., Nguyen P.L., Martinez E., et al. Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy. J Infect Dis 186 (2002) 1092-1097
91. Schacker T.W., Brenchley J.M., Beilman G.J., et al. Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 13 (2006) 556-560
92. Connick E., Lederman M.M., Kotzin B.L., et al. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis 181 (2000) 358-363
93. Pakker N.G., Notermans D.W., de Boer R.J., et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 4 (1998) 208-214
94. Diaz M., Douek D.C., Valdez H., et al. T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment. Aids 17 (2003) 1145-1149
95. Wu H., Connick E., Kuritzkes D.R., et al. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy. AIDS Res Hum Retroviruses 17 (2001) 1231-1240
96. Thomas D.L., Ray S.C., and Lemon S.M. Hepatitis C. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases (2005), Elsevier, Philadelphia 1950-1981
97. Cavert W., Notermans D.W., Staskus K., et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276 (1997) 960-964
98. Guadalupe M., Reay E., Sankaran S., et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77 (2003) 11708-11717
99. Mehandru S., Poles M.A., Tenner-Racz K., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200 (2004) 761-770
100. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 (2005) 1093-1097
101. Mattapallil J.J., Smit-McBride Z., Dailey P., and Dandekar S. Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2. J Virol 73 (1999) 6661-6669
102. Veazey R.S., DeMaria M., Chalifoux L.V., et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 (1998) 427-431
103. Guy-Grand D., and Vassalli P. Gut intraepithelial T lymphocytes. Curr Opin Immunol 5 (1993) 247-252
104. Mowat A.M., and Viney J.L. The anatomical basis of intestinal immunity. Immunol Rev 156 (1997) 145-166
105. Ganusov V.V., and De Boer R.J. Do most lymphocytes in humans really reside in the gut?. Trends Immunol 28 (2007) 514-518
106. Bacchetti P., and Moss A.R. Incubation period of AIDS in San Francisco. Nature 338 (1989) 251-253
107. Mellors J.W., Munoz A., Giorgi J.V., et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126 (1997) 946-954
108. Rodriguez B., Sethi A.K., Cheruvu V., et al. Presenting plasma viremia and CD4 T cell losses in untreated HIV infection. JAMA 296 (2006) 498-1506
109. Powell D.W. Approach to the patient with gastrointestinal disease. In: Goldman L., and Bennet J.C. (Eds). Cecil textbook of medicine (2000), W.B. Saunders and Company, Philadelphia
110. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., and Gordon J.I. Host-bacterial mutualism in the human intestine. Science 307 (2005) 1915-1920
111. Brenchley J.M., Price D.A., Schacker T.W., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12 (2006) 1365-1371
112. Beutler B., Jiang Z., Georgel P., et al. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 24 (2006) 353-389
113. Beignon A.S., McKenna K., Skoberne M., et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions. J Clin Invest 115 (2005) 3265-3275
114. Heil F., Hemmi H., Hochrein H., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
115. Meier A., Alter G., Frahm N., et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded toll-like receptor ligands. J Virol 81 (2007) 8180-8191
116. Funderburg N., Luciano A.A., Jiang W., Rodriguez B., Sieg S.F., and Lederman M.M. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS ONE 3 (2008) e1915
117. Shiow L.R., Rosen D.B., Brdickova N., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440 (2006) 540-544
118. Cecchinato V, Trindade CJ, Heraud JM. Preferential loss of Th17 T cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. In: Proceedings of the 15th conference on retroviruses and opportunistic infections. Boston, MA; 2008.
119. Cervasi B, Brenchley J, Paiardini M. Preferential loss of Th17 CD4 T cells in the gastrointestinal tract of HIV-infected individuals but not SIV-infected sooty mangabeys. In: Proceedings of the 15th conference on retroviruses and opportunistic infections. Boston, MA, February 3-6; 2008.
120. Favre D, Lederer S, Kanwar B. Primary SIV infection causes rapid loss of the balance between TH17 and T regulatory cell populations in pathogenic infection of non-human primates. In: Proceedings of the 15th conference on retroviruses and opportunistic infections. Boston, MA; 2008.
121. Raffatellu M., Santos R.L., Verhoeven D.E., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14 (2008) 421-428
122. Liang S.C., Tan X.Y., Luxenberg D.P., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
123. Biancotto A., Iglehart S.J., Lisco A., et al. Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo. AIDS Res Hum Retroviruses 24 (2008) 453-462
124. Biancotto A., Iglehart S.J., Vanpouille C., et al. HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood 111 (2008) 699-704